TipRanks
pc:kymat

KymaThera

Precision Medicine
KymaThera is a biotechnology company developing next-generation precision medicines for genetically defined diseases. Its lead program, K-1728, is an oral pan-mutant selective PI3Kα inhibitor being developed for cancer and PI3Kα-driven vascular malformations.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation―
Estimated Valuation―
Total Amount Raised$80M
Total Amount Raised$80M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$80M
Latest Funding Amount$80M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation―
Post-Money Valuation―

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Oct 06, 2026
Series B
$80.00M
―

Investors

Investor Name
Funding Round
Alta Partners
Series B
Venrock
Series B
Foresite Capital
Series B
J. Wood Capital
Series B

Related News and Analysis

KymaThera Secures $80 Million Series B to Advance Next-Generation PI3Kα Inhibitor K-1728

KymaThera Secures $80 Million Series B to Advance Next-Generation PI3Kα Inhibitor K-1728

New updates have been reported about KymaThera. KymaThera has raised $80 million in a Series B round led...
3d ago
KYMAT
AI Adoption in Accounting Positions TaxGPT for Efficiency-Focused Growth

AI Adoption in Accounting Positions TaxGPT for Efficiency-Focused Growth

According to a recent LinkedIn post from TaxGPT, the company is positioning its AI technology as a productivity...
33m ago
TAXGP
SecurityPal AI Highlights Trust Center Strategy in Security Compliance Market

SecurityPal AI Highlights Trust Center Strategy in Security Compliance Market

According to a recent LinkedIn post from SecurityPal AI, the company is emphasizing the role of buyer-facing Trust...
33m ago
SEC28
Rocketlane Builds Professional Services Enablement Function With Senior Hire

Rocketlane Builds Professional Services Enablement Function With Senior Hire

According to a recent LinkedIn post from Rocketlane, the company is seeking to build a Professional Services Enablement...
33m ago
ROCKE
Securonix Showcases Integrated Security Operations Platform at Les Assises

Securonix Showcases Integrated Security Operations Platform at Les Assises

According to a recent LinkedIn post from Securonix, the company is actively engaging with customers and prospects at...
33m ago
SEC1D
Moonfare Co‑CEO Flags Mounting Pressure on Private Equity Managers

Moonfare Co‑CEO Flags Mounting Pressure on Private Equity Managers

According to a recent LinkedIn post from Moonfare, Founder and Co‑CEO Steffen Pauls characterizes the current private equity...
33m ago
MOONF
Single Quantum Advances Role in QTRAIN Quantum Communication Consortium

Single Quantum Advances Role in QTRAIN Quantum Communication Consortium

According to a recent LinkedIn post from Single Quantum, the company recently hosted a consortium meeting for the...
33m ago
SIN6A
Customer-Driven Product Development Strategy at InStep AI

Customer-Driven Product Development Strategy at InStep AI

A LinkedIn post from InStep AI highlights how customer feedback is driving ongoing development of its conversational AI...
33m ago
INSTE
Technical Focus on Polyol Systems Highlights Formulation Expertise in Frozen Desserts

Technical Focus on Polyol Systems Highlights Formulation Expertise in Frozen Desserts

According to a recent LinkedIn post from Arboreal, the company is drawing attention to the technical implications of...
33m ago
ARB3W
OneForma Highlights Speech AI Capabilities With Educational Online Event

OneForma Highlights Speech AI Capabilities With Educational Online Event

According to a recent LinkedIn post from OneForma, the company is promoting an online session on October 14...
33m ago
ONEFO